Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress

– Data show verekitug prevents TSLP binding to the TSLP receptor by occupying ligand binding sites –

– Additionally, findings show that verekitug outcompetes TSLP in the presence of preformed heterodimeric receptor complexes –

Read more at globenewswire.com